This content is restricted to site members. If you are an existing user, please log in. New users may register below.
NF 22 µg y 44µg
Each prefilled syringe of Inmunomas NF 22 contains 22 mcg (6 MIU) of recombinant human interferon beta-1a (IFN beta 1a-r- hu) / 0.5 ml. Each prefilled syringe of Inmunomas NF 44 contains 44 mcg (12 MIU) recombinant human interferon beta-1a (IFN beta1a-r- hu) / 0.5 ml.
Mechanism of Action
Treatment for patients with relapsing-remitting multiple sclerosis (RRMS) capable of walking that have experienced at least 2 recurrent neurological dysfunction episodes or flare-ups (relapses) within the two previous years.
Dosage and Administration
16 and older: 1 prefilled syringe of Inmunomas NF 44 three times a week for subcutaneous injection. For patients who may not tolerate the higher dose, administer Inmunomas 22 also three times a week via subcutaneous injection.
Inmunomas NF 22 and 44: 12 prefilled ready-to-use syringes with needles.
By closing the window, you are accepting this message
The material included in this site has been designed for information purposes only. It intends to guide healthcare professionals in the correct use of the medications and satisfy their need for more information.
All texts referring to our prescription products meet the guidelines of the Argentine National Administration of Drugs and Medical Technology (ANMAT, its acronym in Spanish).
Synthon-Bagó Labs recommends that you always talk to a qualified healthcare professional if you have any questions or concerns regarding a specific medical condition.